Online Pharmacy US

Cedars-Sinai investigators funded by the Muscular Dystrophy Association are registering two dozen ambulatory men with Becker muscular dystrophy for a clinical trial of tadalafil (Cialis) as a treatment for the progressive muscle disease. The randomized, placebo-controlled efficacy study will examine the effects of acute tadalafil dosing on muscle blo od flow during a bout of exercise. About 18 million men have been treated with Cialis since its (more…)

(more…)

WALTHAM, Mass. – Decision Resources, Inc., one of the world’s leading research and advisory firms for pharmaceutical and health care issues, finds that a lthough the market for treating erectile dysfunction is dominated by Pfizer’s Viagra, the reported efficacy of Bayer/GlaxoSmithKline’s Levitra and the longer duration of action of Lilly/Icos’s Cialis… (Source: Drug Newswire)

MedWorm Message: Register for MedMatcha, MedWorm’s (more…)

According to BioSpace, the US FDA has approved the oral PDE5 inhibitor tadalafil (Cialis®) for once daily use (2.5 mg and 5 mg) in the treatment of erectile dysfunction (ED). When tadalafil is taken daily, men can attempt sexual activity at any time between doses.

The approval was based on data from three phase III randomized, double-blind, placebo- controlled studies which found that men with ED taking once-daily tadalafil 2.5 mg or 5 (more…)

Health Canada is advising individuals who use the drugs Viagra, Cialis and Levitra to consult their physicians and seek immediate medical attention if they experience sudden vision loss or vision-related problems while taking these drugs. Viagra, Cialis and Levitra are drugs used to treat impotence and erectile dysfunction in men. The specific type of vision loss, called nonarteritic anterior ischemic optic neuropathy (NAION), occurs when blood (more…)

The U.S. Food and Drug Administration has approved labeling changes for erectile dysfunction (ED) drugs in the class th at includes Cialis, Levitra, and Viagra, to display more prominently the potential risk of sudden hearing loss, and to guide consumers on what to do if they experience sudden problems with their hearing. (Source: News-Medical News Feed)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, (more…)

Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Cialis(R) (tadalafil)(1) for once daily use (2.5 mg and 5 mg), an oral medication taken once per day to treat erectile dysfunction (ED). When Cialis for once daily use is taken daily, men can attempt sexual activity at anytime between doses. (Source: Erectile Dysfunction / Premature Ejaculation Ne ws From Medical News Today)

Information for Healthcare Professionals
Sildenafil (marketed as Viagra and Revatio) Vardenafil (marketed as
Levitra) Tadalafil ( marketed as Cialis)
ROCKVILLE, Md., Nov. 14, 2007–FDA SUMMARY [11/2007]:
FDA has received reports of cases of… (Source: Drugs.com – Pharma News)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Rare reports of transient global amnesia have been added to the Cialis and Viagra labels; the condition is already on the Levitra label. WebMD Health News (Sou rce: Medscape Medical News Headlines)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Men with signs of benign prostatic hyperplasia (BPH) can be helped with a daily dose of erectile dysfunction drug tadalafil (Cialis) to relieve associated lower urinary tract symptoms (LUTS), according to a new study published in the October 2008 issue of The Journa l of Urology. (Source: News-Medical News Feed)